Cargando…

Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment

Schizophrenia is frequently a chronic and disabling disorder, characterized by heterogeneous positive and negative symptom constellations. The objective of this review was to provide information that may be useful for clinicians treating patients with negative symptoms of schizophrenia. Negative sym...

Descripción completa

Detalles Bibliográficos
Autores principales:	Correll, Christoph U, Schooler, Nina R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041437/ https://www.ncbi.nlm.nih.gov/pubmed/32110026 http://dx.doi.org/10.2147/NDT.S225643

Ejemplares similares

Depressive Symptoms and PANSS Symptom Dimensions in Patients With Predominant Negative Symptom Schizophrenia: A Network Analysis
por: Demyttenaere, Koen, et al.
Publicado: (2022)

What is the Best Latent Structure of Negative Symptoms in Schizophrenia? A Systematic Review
por: Haguiara, Bernardo, et al.
Publicado: (2021)

O4.2. THE PREVENTION OF RELAPSE AND HOSPITALIZATION IN FIRST EPISODE AND EARLY PHASE SCHIZOPHRENIA: RESULTS FROM THE PRELAPSE TRIAL
por: Kane, John, et al.
Publicado: (2020)

Pharmacologic treatment of schizophrenia
por: Kane, John M., et al.
Publicado: (2010)

Disentangling the symptoms of schizophrenia: Network analysis in acute phase patients and in patients with predominant negative symptoms
por: Demyttenaere, Koen, et al.
Publicado: (2021)

MDMA for the Treatment of Negative Symptoms in Schizophrenia
por: Arnovitz, Mitchell D., et al.
Publicado: (2022)

New Developments in the Treatment of Schizophrenia: An Expert Roundtable
por: Kantrowitz, Joshua T, et al.
Publicado: (2023)

T175. THE GUT-MICROBIOTA AS A TARGET FOR THE TREATMENT OF NEGATIVE SYMPTOMS OF SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF CONTROLLED TRIALS OF ADD-ON STRATEGIES
por: Minichino, Amedeo, et al.
Publicado: (2020)

Clinical predictors of therapeutic response to antipsychotics in schizophrenia
por: Carbon, Maren, et al.
Publicado: (2014)

S48. INTER-RATER RELIABILITY OF PANSS-6 SCHIZOPHRENIA SEVERITY RATINGS OBTAINED USING THE SIMPLIFIED NEGATIVE AND POSITIVE SYMPTOMS INTERVIEW (SNAPSI)
por: Kølbæk, Pernille, et al.
Publicado: (2018)

Negative symptoms in schizophrenia
por: Mitra, Sayantanava, et al.
Publicado: (2016)

Prediction Analysis for Transition to Schizophrenia in Individuals at Clinical High Risk for Psychosis: The Relationship of DAO, DAOA, and NRG1 Variants with Negative Symptoms and Cognitive Deficits
por: Jagannath, Vinita, et al.
Publicado: (2017)

Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia
por: Meyer, Jonathan M., et al.
Publicado: (2023)

Assessment and Treatment of Negative Symptoms in Schizophrenia—A Regional Perspective
por: Bitter, Istvan, et al.
Publicado: (2022)

EPA guidance on assessment of negative symptoms in schizophrenia
por: Galderisi, S., et al.
Publicado: (2021)

Interplay between negative symptoms, time spent doing nothing, and negative emotions in patients with schizophrenia spectrum disorders: results from a 37-site study
por: D’Anna, Giulio, et al.
Publicado: (2023)

NEGATIVE SYMPTOMS AND NEGATIVE SCHIZOPHRENIA
por: Chaturvedi, S.K., et al.
Publicado: (1984)

Treatment of early non-response in patients with schizophrenia: assessing the efficacy of antipsychotic dose escalation
por: Loebel, Antony, et al.
Publicado: (2015)

Treatment of negative symptoms in schizophrenia: a challenge for clinical research
por: Schmitt, Andrea, et al.
Publicado: (2023)

Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
por: Kane, John M., et al.
Publicado: (2021)

Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia
por: Mathews, Maju, et al.
Publicado: (2019)

Developments in Biological Mechanisms and Treatments for Negative Symptoms and Cognitive Dysfunction of Schizophrenia
por: Wu, Qiongqiong, et al.
Publicado: (2021)

Acupuncture as Add-On Treatment of the Positive, Negative, and Cognitive Symptoms of Patients with Schizophrenia: A Systematic Review
por: van den Noort, Maurits, et al.
Publicado: (2018)

Therapeutic Use of VR Serious Games in the Treatment of Negative Schizophrenia Symptoms: A Systematic Review
por: Miranda, Beatriz, et al.
Publicado: (2022)

Efficacy of Serotonin and Dopamine Activity Modulators in the Treatment of Negative Symptoms in Schizophrenia: A Rapid Review
por: Brasso, Claudio, et al.
Publicado: (2023)

Neurodevelopmental and environmental hypotheses of negative symptoms of schizophrenia
por: Limosin, Frédéric
Publicado: (2014)

Current perspectives in treating negative symptoms of schizophrenia: A narrative review (Review)
por: Căpățînă, Octavia O., et al.
Publicado: (2021)

Exploration of Treatment-Resistant Schizophrenia Subtypes Based on a Survey of 204 US Psychiatrists
por: Correll, Christoph U, et al.
Publicado: (2019)

Cost of antipsychotic polypharmacy in the treatment of schizophrenia
por: Zhu, Baojin, et al.
Publicado: (2008)

Negative symptoms in children and adolescents with early-onset psychosis and at clinical high-risk for psychosis: systematic review and meta-analysis
por: Salazar de Pablo, Gonzalo, et al.
Publicado: (2023)

EPA guidance on treatment of negative symptoms in schizophrenia
por: Galderisi, S., et al.
Publicado: (2021)

Efficacy of Atypical Antipsychotics in the Management of Acute Agitation and Aggression in Hospitalized Patients with Schizophrenia or Bipolar Disorder: Results from a Systematic Review
por: CORRELL, Christoph U., et al.
Publicado: (2016)

Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development
por: Strauss, Gregory P., et al.
Publicado: (2021)

INTER-RATER RELIABILITY OF THE SCALE FOR ASSESSMENT OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
por: Kota, S.K., et al.
Publicado: (1986)

Validation of the Korean-Version of the Clinical Assessment Interview for Negative Symptoms of Schizophrenia (CAINS)
por: Jung, Sung Il, et al.
Publicado: (2016)

The Functional Significance of Affect Recognition, Neurocognition, and Clinical Symptoms in Schizophrenia
por: Huang, Charles Lung-Cheng, et al.
Publicado: (2017)

S46. THE VALIDITY AND SENSITIVITY OF PANSS-6 IN TREATMENT-RESISTANT SCHIZOPHRENIA
por: Ostergaard, Soren Dinesen, et al.
Publicado: (2018)

Adaptation of a peer based online emotional support program as an adjunct to treatment for people with schizophrenia-spectrum disorders
por: Baumel, Amit, et al.
Publicado: (2016)

Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists
por: Correll, Christoph U., et al.
Publicado: (2019)

NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND DEPRESSION
por: Chaturvedi, S.K., et al.
Publicado: (1985)

Cannot write session to /tmp/vufind_sessions/sess_4jn69vqagel07o2qj00e7kf9ap